Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial
达格列净预防2型糖尿病患者肾脏疾病：DECLARE-TIMI 58试验的事后分析
期刊:
影响因子:
doi:10.2337/dc22-0382
Mosenzon, Ofri; Raz, Itamar; Wiviott, Stephen D; Schechter, Meir; Goodrich, Erica L; Yanuv, Ilan; Rozenberg, Aliza; Murphy, Sabina A; Zelniker, Thomas A; Langkilde, Anna Maria; Gause-Nilsson, Ingrid A M; Fredriksson, Martin; Johansson, Peter A; Wilding, John P H; McGuire, Darren K; Bhatt, Deepak L; Leiter, Lawrence A; Cahn, Avivit; Dwyer, Jamie P; Heerspink, Hiddo J L; Sabatine, Marc S
